Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LMWH with TACE in Hepatocellular Carcinoma
NCT00827554Phase 3Completed
- Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Start
- Dec 2008
- Primary completion
- Aug 2011
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nadroparin in hepatocellular carcinoma (HCC), sponsored by Eastern Hepatobiliary Surgery Hospital. Started Dec 2008; status: completed.
02
Drugs
nadroparin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00827554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00827554.